Title

Description description description. Description description description. Description description description.

TASIGNA Patient Stories

MEET OTHERS WHO ARE MAKING THEIR BLOOD HEARD.

No one understands what you’re going through like another person with Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP). That’s the point behind the real people and real stories of the following videos. Actual patients on TASIGNA® (nilotinib) capsules share their experiences in living with—and managing—their condition. Each patient has a different experience and individual results may vary.

Watch Brianne's Story

Meet Brianne

 

A music teacher at an elementary school, Brianne learned she had Ph+ CML in 2016 when she was in her mid-thirties. Her diagnosis came as a shock based on her active lifestyle as a runner and yoga instructor. Brianne talks about starting on TASIGNA and the importance of having honest conversations with her doctor. As a single person, she also discusses the value of stitching together her own support network.

Brianne is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Brianne

Watch Brianne's Story

 

A music teacher at an elementary school, Brianne learned she had Ph+ CML in 2016 when she was in her mid-thirties. Her diagnosis came as a shock based on her active lifestyle as a runner and yoga instructor. Brianne talks about starting on TASIGNA and the importance of having honest conversations with her doctor. As a single person, she also discusses the value of stitching together her own support network.

Brianne is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Watch Brian's Story

Meet Brian

Brian Boyle is a professional hockey player who was diagnosed with Ph+ CML at just 32. In Brian’s patient story, he shares the shock of his initial diagnosis in 2017 and how TASIGNA has helped. Brian explains that he makes it a priority to take TASIGNA twice a day—even with his demanding job and a travel schedule that takes him all across North America. 

Brian is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Brian

Watch Brian's Story

Brian Boyle is a professional hockey player who was diagnosed with Ph+ CML at just 32. In Brian’s patient story, he shares the shock of his initial diagnosis in 2017 and how TASIGNA has helped. Brian explains that he makes it a priority to take TASIGNA twice a day—even with his demanding job and a travel schedule that takes him all across North America. 

Brian is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Watch Alex's Story

Meet Alex

A math teacher, Alex learned he had Ph+ CML in 2018, and his wife Kathryn has been by his side from the start. The couple explains their Ph+ CML story and how Alex’s diagnosis has brought them closer together. Alex discusses the impact Ph+ CML has had on their family, including their 2 young sons. He talks about the importance of taking TASIGNA and understanding the results of his blood tests.

Alex is a real patient taking TASIGNA for Ph+ CML in chronic phase. Alex and his wife Kathryn were compensated by Novartis for participating in this patient story.

Meet Alex

Watch Alex's Story

A math teacher, Alex learned he had Ph+ CML in 2018, and his wife Kathryn has been by his side from the start. The couple explains their Ph+ CML story and how Alex’s diagnosis has brought them closer together. Alex discusses the impact Ph+ CML has had on their family, including their 2 young sons. He talks about the importance of taking TASIGNA and understanding the results of his blood tests.

Alex is a real patient taking TASIGNA for Ph+ CML in chronic phase. Alex and his wife Kathryn were compensated by Novartis for participating in this patient story.

Watch Virginia's Story

Meet Virginia

Living with Ph+ CML since 2010, Virginia switched to TASIGNA early on in her treatment after experiencing side effects on another medication. In her patient story, Virginia explains how she was devastated by her diagnosis given her active and healthy lifestyle. She discusses the importance of having the right treatment, the right attitude, and a good outlook on life. Virginia’s advice: “Take your medicine. Don’t skip it.”

Virginia is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Virginia

Watch Virginia's Story

Living with Ph+ CML since 2010, Virginia switched to TASIGNA early on in her treatment after experiencing side effects on another medication. In her patient story, Virginia explains how she was devastated by her diagnosis given her active and healthy lifestyle. She discusses the importance of having the right treatment, the right attitude, and a good outlook on life. Virginia’s advice: “Take your medicine. Don’t skip it.”

Virginia is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Watch Mitch's Story

Meet Mitch

A native of Maine, Mitch was diagnosed with Ph+ CML in 2004, when there was only one treatment available. In his patient story, Mitch explains how he developed side effects to the medication he was first prescribed. Working closely with his doctor, Mitch switched to TASIGNA. While Mitch has high expectations of his health care team, he also has high expectations of himself to keep up with every aspect of his treatment plan.

Mitch is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Mitch

Watch Mitch's Story

A native of Maine, Mitch was diagnosed with Ph+ CML in 2004, when there was only one treatment available. In his patient story, Mitch explains how he developed side effects to the medication he was first prescribed. Working closely with his doctor, Mitch switched to TASIGNA. While Mitch has high expectations of his health care team, he also has high expectations of himself to keep up with every aspect of his treatment plan.

Mitch is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Watch Jessica's Story

Meet Jessica

Jessica was in her 30s when she learned the shocking news that she had Ph+ CML. That was in 2012 and Jessica has been taking TASIGNA ever since. Over the years, Jessica has learned the importance of being her own advocate. In her patient story, Jessica explains how she has educated herself about Ph+ CML and always shows up to her doctor’s appointments with a long list of questions.  

Jessica is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Jessica

Watch Jessica's Story

Jessica was in her 30s when she learned the shocking news that she had Ph+ CML. That was in 2012 and Jessica has been taking TASIGNA ever since. Over the years, Jessica has learned the importance of being her own advocate. In her patient story, Jessica explains how she has educated herself about Ph+ CML and always shows up to her doctor’s appointments with a long list of questions.  

Jessica is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Watch Mary Jo’s Story

Meet Mary Jo

Just 6 weeks after having twin boys, Mary Jo was diagnosed with Ph+ CML in chronic phase. Her doctor prescribed TASIGNA, which helped bring the disease under control. After more than 3 years on TASIGNA, Mary Jo participated in a clinical trial for stopping treatment with TASIGNA. Learn about the criteria she had to meet and how she worked with her doctor to decide how to move forward.

Mary Jo is a real patient who has taken TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.

Meet Mary Jo

Watch Mary Jo’s Story

Just 6 weeks after having twin boys, Mary Jo was diagnosed with Ph+ CML in chronic phase. Her doctor prescribed TASIGNA, which helped bring the disease under control. After more than 3 years on TASIGNA, Mary Jo participated in a clinical trial for stopping treatment with TASIGNA. Learn about the criteria she had to meet and how she worked with her doctor to decide how to move forward.

Mary Jo is a real patient who has taken TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for participating in this patient story.